(1 - 17 from 17
)
News | Astellas Pharma Inc.www.astellas.com › news
www.astellas.com
20 Sept — ... which we expect to obtain during the fourth quarter of 2017,” said Vijay Samant, President and Chief Executive Officer, Vical.
Astellas and Vical Announce Top-Line Results for Phase 3 Trial of...
www.globenewswire.com
“The Phase 3 trial outcome is disappointing,” said Vijay Samant, Vical's Chief Executive Officer. “Astellas and Vical employees, the investigators ...
Vical Announces Restructuring and Staff Reduction Nasdaq:VICL
www.globenewswire.com
... programs are adequately resourced to create maximum shareholder value," said Vijay Samant, Vical's President and Chief Executive Officer.
sorted by relevance / date